Skip to main content

Table 1 Study Population Characteristics at the Time of Entry

From: Evaluation of Different Combined Regimens in the Treatment of Cholinergic Urticaria

Variable Group A (92) Mean ± SD (Average) Group B (77) Mean ± SD (Average) Group C (82) Mean ± SD (Average)
Age, y 21 ± 5 (16-29) 23 ± 4 (17-27) 23 ± 3 (19-29)
WBC total count 6600 ± 120 (5100-9200) 7500 ± 800 (6000-9000) 7600 ± 960 (5900-10, 600)
Neutrophil % 61 ± 5 (52-70) 60 ± 6 (49-72) 63 ± 6 (53-74)
Lymphocyte % 29 ± 2 (21-40) 31 ± 6 (19-41) 31 ± 6 (19-42)
Eosinophil % 7 ± 1(5-9) 7 ± 1(5-8) 7 ± 1(5-9)
Monocyte % 2 ± 1(1-6) 2 ± 1(0-6) 1 ± 1(0-5)
Basophil % 0 (0-2) 0 (0-1) 0 (0-1)
ESR, mm/h 9.5 ± 3(4-20) 9 ± 2(6-12) 12 ± 5(4-36)
PCV % 42 ± 2 (38-44) 42 ± 2 (40-44) 42 ± 2 (36-42)
Platelets number 172, 000 ± 83, 900 (150, 000-180, 000) 170, 000 ± 32, 400 (148, 000-175, 000) 165, 000 ± 9750 (146, 000-177, 000)
  1. ESR, erythrocyte sedimentation rate; PCV, packed cell volume;